Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 10, Issue 1, 2003, Pages 10-15

  Cacoub, P ^a   Bourliere M ^b   Hausfater, P ^a   Charlotte, F ^a   Khiri, H ^c   Toci, S ^c   Piette, J C ^a   Poynard, T ^a   Halfon, P ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT JOSEPH   (France)

^c Laboratoire Alphabio   (France)

Author keywords

B cell non Hodgkin lymphoma; CD81 receptor; Hepatitis C virus; Lymphoma; Lymphoproliferative disease; Mixed cryoglobulinaemia

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD5 ANTIGEN; CD81 ANTIGEN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CHRONIC HEPATITIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD5; AUTOIMMUNITY; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CRYOGLOBULINEMIA; FEMALE; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LYMPHOMA, B-CELL; MALE; MEMBRANE PROTEINS; MIDDLE AGED;

EID: 0345505663     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00380.x     Document Type: Article

References (40)

1. Pawlotsky JM, Roudot-Thoraval F, Simmonds P et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173.
2. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620.
3. Cacoub P, Poynard T, Ghilliani P et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999; 42: 2204-2212.
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
5. Cacoub P, Lunel-Fabiani F, Musset L et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994; 96: 124-132.
6. Cacoub P, Renou C, Rosenthal E et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine 2000; 79: 55-64.
7. Lunel-Fabiani F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300.
8. De Rosa G, Gobbo MLDe Renzo Aet al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997; 55: 77-82.
9. Mazzaro C, Zagonel V, Monfardini S et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-550.
10. Ferri C, Caracciolo F, Zignego AL et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394.
11. Silvestri F, Pipan C, Barillari G et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-4301.
12. Zuckerman E, Zuckerman T, Levine AM et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428.
13. Hausfater P, Cacoub P, Bernard N et al. Hepatitis C virus infection and malignant lymphoproliferative disease: French national study. Am J Hematol 2000; 64: 107-111.
14. De Vita S, Sacco C, Sansonno D et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-782.
15. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-941.
16. Higginbottom A, Quinn ER, Kuo CC et al. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol 2000; 74: 3642-3649.
17. Levy S, Todd SC, Maecker HT. CD81(TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998; 16: 89-109.
18. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361-1392.
19. Halfon P, Khiri H, Gerolami V et al. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996; 25: 307-311.
20. Cacoub P, Musset L, Hausfater P et al. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Clin Exp Immunol 1998; 113: 48-54.
21. Musset L, Diemert MC, Taibi F et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38: 798-802.
22. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. Am J Med 1974; 57: 775-788.
23. The French Metavir cooperative study group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
24. Knodeli RG, Ishak KG, Black WC et al. Formulation and application of numerical scoring systems for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 5: 431-435.
25. Zignego AL, Ferri C, Giannini C et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-34.
26. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996; 25: 427-432.
27. Musset L, Lunel-Fabiani F, Cacoub P et al. Increased serum immunoglobulin G1 levels in hepatitis C virus infection. Hepatology 1995; 21: 1755-1757.
28. Cacoub P, Frangeul L, Lunel F. Hepatitis G and mixed cryoglobulinemia (letter). Ann Intern Med 1997; 126: 1002.
29. Cacoub P, Boukli N, Hausfater P et al. Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia. Ann Rheum Dis 1998; 57: 422-424.
30. Fearon DT, Carter RH. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 1995; 13: 127-149.
31. Flint M, Maidens C, Loomis-Price LD et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol. 1999; 73: 6235-6244.
32. Kronenberg B, Ruster B, Weber S et al. Influence of interferon alpha on CD 81 expression in HCV positive patients. San Diego: AGA, 2000.
33. Maecker HT, Levy S. Normal lymphocyte development but delayed humoral immune response in CD-81 null mice. J Exp Med 1997; 185: 1505-1510.
34. Cacoub P, Renou C, Kerr G et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 2001; 9: 2118-2124.
35. Sasso EH. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection. Ann Med Interne 2000; 15: 30-40.
36. Sasso EH, Johnson T, Kipps TJ. Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number. J Clin Invest 1996; 97: 2074-2080.
37. Sasso EH, Ghiliani P, Musset L, Piette JC, Cacoub P. Effect of 51p1 gene copy number (V1-69 locus) on production of hepatitis C cryoglobulins. Clin Exp Immunol 2000; 122: 1-7.
38. La Civita L, Zignego AL, Monti M, Longobardo G, Pasero G, Ferri C. Mixed cryoglobulinemia as a possible preneoplastic disorder. Arthritis Rheum 1995; 38: 1859-1860.
39. Allander T, Drakenberg K, Beyene A et al. Recombinant human monoclonal antibodies aganist different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. J Gen Virol 2000; 81: 2451-2459.
40. Chan HC, Hadlock KG, Foung SKH, Levy S. The VH 1-69 gene is preferentially used both by hepatitis C virus-associated B-cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001; 97: 1023-6.